Back
Ionis Pharmaceuticals, Inc. (IONS)
BiotechnologyIONS · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$45.26
+4.55%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$-2.38
ROE
-67.6%
Gross margin
10.9%
Debt/Equity
5.31x
Revenue growth
87.0%
Ionis Pharmaceuticals, Inc. — company intelligence
Earnings surprises
Q2 2026$-0.69 vs $-1.09 est+36.7%
Q1 2026$-0.56 vs $-0.93 est+39.7%
Q4 2025$-1.41 vs $-1.35 est-4.6%
Q3 2025$-0.80 vs $-1.26 est+36.4%
Analyst consensus · 32 analysts
25 Buy7 Hold0 Sell
Updated Oct 6, 2026
Insider activity · 90 days
4 buys0 sellsnet +26,798 shares
BENNETT C FRANKgift 110 · Aug 31, 2026
O'NEIL PATRICK R.gift 63 · Aug 31, 2026
Birchler Briangift 58 · Aug 31, 2026
Recent SEC filings
8-K — Material event reportSep 4, 2026
8-K — Material event reportSep 4, 2026
4 — Insider transaction reportSep 2, 2026
Latest news
Moat Stocks Retreat As Market Breadth Narrows — SeekingAlpha · 4d ago
Cathie Wood Makes $64 Million Bet on Two Stocks — Yahoo · 1w ago
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation — Yahoo · 1w ago
Alnylam Pharmaceuticals: More Than Meets The Eye After CARDIO-TTRansform — SeekingAlpha · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.